Literature DB >> 8061447

Repeat cerebral blood volume assessment with first-pass MR imaging.

V M Runge1, J E Kirsch, J W Wells, J N Dunworth, L Hilaire, C E Woolfolk.   

Abstract

The feasibility of performing multiple first-pass studies with dynamic, contrast material-enhanced magnetic resonance (MR) imaging was evaluated in a cat model of acute middle cerebral artery (MCA) ischemia. Two dynamic series of SSFP (steady-state free precession) images were acquired in each animal (n = 5) with a conventional 1.5-T imager. The initial first-pass study was acquired at 60 minutes after MCA occlusion, and the second study at 70 minutes, with each performed during an intravenous bolus injection of a 0.5 mmol/kg dose of gadoteridol. In both first-pass studies, differentiation of normal and ischemic gray and white matter was highly statistically significant. At a threshold of P < .01, no statistically significant difference in the peak signal intensity between the first and second studies was noted. A difference between the two studies in the recovery to baseline was seen, presumably due to T1 effects. First-pass MR studies can be repeated within the time frame of a single clinical examination, expanding their utility.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8061447     DOI: 10.1002/jmri.1880040335

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  7 in total

1.  Percentage signal recovery derived from MR dynamic susceptibility contrast imaging is useful to differentiate common enhancing malignant lesions of the brain.

Authors:  R Mangla; B Kolar; T Zhu; J Zhong; J Almast; S Ekholm
Journal:  AJNR Am J Neuroradiol       Date:  2011-04-21       Impact factor: 3.825

2.  Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.

Authors:  Ramon F Barajas; Jamie S Chang; Mark R Segal; Andrew T Parsa; Michael W McDermott; Mitchel S Berger; Soonmee Cha
Journal:  Radiology       Date:  2009-09-29       Impact factor: 11.105

3.  Contrast-enhanced MR imaging in acute ischemic stroke: T2* measures of blood-brain barrier permeability and their relationship to T1 estimates and hemorrhagic transformation.

Authors:  R E Thornhill; S Chen; W Rammo; D J Mikulis; A Kassner
Journal:  AJNR Am J Neuroradiol       Date:  2010-02-25       Impact factor: 3.825

4.  Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis.

Authors:  Andrés Server; Tone E Døli Orheim; Bjørn A Graff; Roger Josefsen; Theresa Kumar; Per H Nakstad
Journal:  Neuroradiology       Date:  2010-07-13       Impact factor: 2.804

5.  Comparison of first-pass and second-bolus dynamic susceptibility perfusion MRI in brain tumors.

Authors:  M Vittoria Spampinato; Caroline Wooten; Margaret Dorlon; Nada Besenski; Zoran Rumboldt
Journal:  Neuroradiology       Date:  2006-09-30       Impact factor: 2.804

6.  Measurements of diagnostic examination performance and correlation analysis using microvascular leakage, cerebral blood volume, and blood flow derived from 3T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in glial tumor grading.

Authors:  Andrés Server; Bjørn A Graff; Tone E Døli Orheim; Till Schellhorn; Roger Josefsen; Øystein B Gadmar; Per H Nakstad
Journal:  Neuroradiology       Date:  2010-09-21       Impact factor: 2.804

7.  Uninterpretable Dynamic Susceptibility Contrast-Enhanced Perfusion MR Images in Patients with Post-Treatment Glioblastomas: Cross-Validation of Alternative Imaging Options.

Authors:  Young Jin Heo; Ho Sung Kim; Ji Eun Park; Choong-Gon Choi; Sang Joon Kim
Journal:  PLoS One       Date:  2015-08-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.